Mr. Bruce Goodwin
JPL CBRND Enabling Biotechnologies (EB)
Mr. Goodwin is the Joint Project Lead (JPL) for the Chemical, Biological, Radiological and Nuclear Defense (CBRND) Enabling Biotechnologies (EB). He started in his current position in April 2020 and he reports directly to the Joint Program Executive Officer for CBRND. As the JPL CBRND EB, Mr. Goodwin is responsible for leading EB’s mission to provide new and improved medical countermeasures to enable a single treatment for many threats, rapid medical countermeasure responses, genomic sequencing and the capability to diagnose CBRN threats before the onset of symptoms. As well as to modernize the DoD’s approach across the medical countermeasure (MCM) spectrum by building, maturing, and integrating capabilities and infrastructure to support accelerated MCM development, manufacturing, testing, and deployment. Mr. Goodwin earned a Bachelor of Science in Biology from Salisbury University. Mr. Goodwin is Level III certified in Program Management from the Defense Acquisition University.
Download Biography